Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn budgeting strategies focused on saving money through deliberate allocations, expense trimming, and goal-driven planning.
18,873 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
In a landmark move, PACT confirms its native $PACT token is now listed on Kraken, MEXC, and Gate, boosting on-chain c...
A wave of altcoins posted double-digit gains while Bitcoin steadied. Learn which coins led the rally, why it happened...
Axos Financial has delivered a notable 12-month gain, with a recent fund trim adding a twist to the story. This artic...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
Logan Finance rolls out a premium Open Road Elevated tier to serve high-net-worth borrowers with larger loan needs ou...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Taiwan Semiconductor Manufacturing Company has delivered remarkable returns, yet the question remains: with a rally l...
NVIDIA’s GTC keynote spotlighted two moves that could reshape AI hardware and software. This guide breaks down the hi...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
A major enterprise deal could unlock rapid upside for Nebius NBIS. This article breaks down how the contract might af...
A major regulatory milestone changes how crypto assets are viewed in the U.S. This guide breaks down the new classifi...